Menopausal patients are most interested in learning more about non-hormonal treatments to address their symptoms, according to the results of an international survey led by the Menopause Priority ...

Just as Andrew Witty of UnitedHealth Group did in a call with investors last month, CVS Health’s CEO David Joyner defended ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

Results show improved functional outcomes for people with Duchenne muscular dystrophy who are ambulatory. Elevidys, which is ...

CVS Health’s total revenue for the full year 2024 increased 4.2% to $372.8 billion, but within the healthcare benefits ...

We spoke recently with Craig Burton, MBA, executive director of the Biosimilars Council, a trade and lobbying group for the ...

The respiratory tract’s microbial microflora plays a significant role in determining the severity of RSV infections and the ...

The PDUFA action date for an FDA decision for linvoseltamab to treat adult patients with relapsed/refractory multiple myeloma ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

An expert discusses how key symptoms of narcolepsy, such as excessive daytime sleepiness and cataplexy, impact daily functioning and quality of life, along with the primary differences between type 1 ...

A panelist discusses how the potential of neurokinin-targeted therapies to provide targeted symptom relief with fewer side effects represents a significant advancement in menopause care while noting ...

Capital Rx, a pharmacy benefit manager and administrator, has announced Judi Health, the first centralized claims processing ...